Mostrar el registro sencillo del ítem

dc.contributor.authorHerrera-R, Angie
dc.contributor.authorCastrillón, Wilson
dc.contributor.authorOtero, Elver
dc.contributor.authorRuiz, Esneyder
dc.contributor.authorCarda, Miguel
dc.contributor.authorAgut, Raúl
dc.contributor.authorNaranjo Preciado, Tonny
dc.contributor.authorMoreno, Gustavo
dc.contributor.authorMaldonado, María Elena
dc.contributor.authorCardona Galeano, Wilson Isidro
dc.date.accessioned2018-09-28T10:49:00Z
dc.date.available2018-09-28T10:49:00Z
dc.date.issued2018
dc.identifier.citationHerrera-R, A., Castrillón, W., Otero, E. et al. Med Chem Res (2018) 27: 1893. https://doi.org/10.1007/s00044-018-2202-0ca_CA
dc.identifier.issn1054-2523
dc.identifier.issn1554-8120
dc.identifier.urihttp://hdl.handle.net/10234/176375
dc.description.abstractA series of styrylcoumarins were obtained via Mizoroki-Heck reactions between 3-bromo-4-methyl7-(octyloxy)-2H-chromen-2-one or 2-oxo-2H-chromen-7-yl trifluoromethanesulfonate and functionalized styrenes. The structures of the products were elucidated by spectroscopic analysis. All compounds were evaluated against SW480 and CHO-K1 cell lines. A number of hybrids showed good antiproliferative activity. Among the tested compounds, hybrids 6e, 10c and 10d, exhibited the highest activity (IC50- SW480/48h = 6,92; 1,01 and 5,33 µM, respectively) and selectivity (IS48h = >400; 67,8 and 7,2, respectively). In addition, these compounds were able to preserve their activities over time. The results achieved by these hybrids were even better than the lead compounds (coumarin and resveratrol) and the standard drug (5-FU). As regards structure-activity relationship it seems that the location of the styryl group on the coumarin structure and the presence of the hydroxyl group on the phenyl ring were determinant for the activity.ca_CA
dc.format.extent25 p.ca_CA
dc.format.mimetypeapplication/pdfca_CA
dc.language.isoengca_CA
dc.publisherSpringer Verlagca_CA
dc.relation.isPartOfMedicinal Chemistry Research (2018) 27ca_CA
dc.rights© Springer Science+Business Media, LLC, part of Springer Nature 2018. “This is a post-peer-review, pre-copyedit version of an article published in Medicinal Chemistry Research. The final authenticated version is available online at: http://dx.doi.org/10.1007/s00044-018-2202-0”ca_CA
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/*
dc.subjectcoumarinca_CA
dc.subjectstyrylcoumarinca_CA
dc.subjectantiproliferative activityca_CA
dc.subjectcolorectal cancerca_CA
dc.titleSynthesis and Antiproliferative Activity of 3 and 7-Styrylcoumarinsca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttps://doi.org/10.1007/s00044-018-2202-0
dc.relation.projectIDCODI 2014-808ca_CA
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_CA
dc.relation.publisherVersionhttps://link.springer.com/article/10.1007/s00044-018-2202-0ca_CA
dc.date.embargoEndDate2019-06-20
dc.type.versioninfo:eu-repo/semantics/acceptedVersionca_CA


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem